SFS
TXMD icon

Sowell Financial Services’s TherapeuticsMD TXMD Stock Holding History

Sowell Financial Services’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-85
Closed -$5K – 2561
2021
Q1 		$5K Hold
85
– – ﹤0.01% 2619
2020
Q4 		$5K Hold
85
– – ﹤0.01% 2294
2020
Q3 		$7K Buy
+85
New +$6.78K ﹤0.01% 1917

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Sowell Financial Services's TXMD Position: Q2 2021 in Review

Sowell Financial Services sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 85 shares — an estimated $5K sold.

Sowell Financial Services first reported a position in TXMD in Q3 2020 and held it in 3 quarters. The position peaked at $7K in Q3 2020. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Sowell Financial Services reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 85 TherapeuticsMD shares in Q2 2021, an estimated $5K.
  • Sowell Financial Services first reported a position in TherapeuticsMD in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's TherapeuticsMD position peaked at $7K in Q3 2020.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.